Published lot report

Lot RT3042126: Retatrutide 30mg

This is the third-party report published for lot RT3042126. Check that the lot printed on your vial matches exactly; a report for a different lot does not describe your vial.

Compound: Retatrutide 30mg
Lot: RT3042126
Laboratory: Vanguard Laboratory
Reported: 2026-05-11
Method: HPLC-UV/VIS
Reported purity: >99.80% ± 0.18%
Measured quantity: 29.84 mg

Certificate of analysis for Retatrutide 30mg, lot RT3042126, from Vanguard Laboratory — Report image as issued by Vanguard Laboratory.

Retatrutide — catalog listing for this compound.

HPLC vs LC-MS — what the listed method does and does not prove.

Peptide COA checklist — ten checks to run on this report.

All published reports — request a report for a lot that is not listed.

Research use only (RUO): sold solely for qualified laboratory, in-vitro, and analytical work. Not for human or animal use, ingestion, administration, or diagnosis/treatment. Not FDA approved. An RUO label alone does not establish that a sale, possession, shipment, or use is lawful.